Identification and Validation of Biomarkers for Breast Cancer Resistance Protein
Latest Information Update: 29 Jan 2024
At a glance
- Drugs Eltrombopag (Primary) ; Rosuvastatin (Primary)
- Indications Acute myeloid leukaemia; Acute radiation syndrome; Aplastic anaemia; Atherosclerosis; Cardiovascular disorders; Chronic myelomonocytic leukaemia; Hypercholesterolaemia; Hyperlipidaemia; Hypertriglyceridaemia; Idiopathic thrombocytopenic purpura; Myelodysplastic syndromes; Thrombocytopenia; Transplant rejection
- Focus Biomarker; Pharmacokinetics
- Acronyms BCRPmarker
- 19 Jan 2024 Planned End Date changed from 1 Dec 2023 to 1 Dec 2024.
- 19 Jan 2024 Planned primary completion date changed from 1 Dec 2023 to 1 Dec 2024.
- 18 Sep 2023 Planned End Date changed from 1 Sep 2023 to 1 Dec 2023.